Succinylcholine Chloride
These highlights do not include all the information needed to use Succinylcholine Chloride Injection, USP safely and effectively. See full prescribing information for Succinylcholine Chloride Injection, USP. Succinylcholine Chloride Injection, USP, for intravenous or intramuscular use Initial U.S. Approval: 1952
Approved
Approval ID
488e1689-84d4-4f96-ac85-fa0cbc661cb6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 26, 2023
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Succinylcholine Chloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9338
Application NumberANDA213229
Product Classification
M
Marketing Category
C73584
G
Generic Name
Succinylcholine Chloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateJune 26, 2023
FDA Product Classification
INGREDIENTS (7)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SUCCINYLCHOLINE CHLORIDE DIHYDRATEActive
Quantity: 20 mg in 1 mL
Code: 8L0S1G435E
Classification: ACTIR